MedTrace Logo

Temperature Mapping of the Prostate With the Wallterm™ System

NCT00662350 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2010-02-04

No results posted yet for this study

Summary

To measure intra-prostatic temperatures and evaluate the shape and size of necrotic lesions achieved under the standard treatment protocol in men with benign prostatic hyperplasia (BPH).

Conditions

  • Benign Prostatic Hyperplasia

Interventions

DEVICE

The Wallterm™ System

The Wallterm™ System is intended to ablate prostatic glandular and stromal tissue to relieve moderate to severe symptoms of outflow obstruction secondary to benign prostatic hyperplasia (BPH).

Sponsors & Collaborators

  • Pnn Medical A/S

    lead INDUSTRY

Principal Investigators

  • Jørgen Nordling, Professor · Urological Dep., Herlev Hospital, Denmark

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-07-31
Completion
2009-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00662350 on ClinicalTrials.gov